Thank you.

90 years ago, FDR stood at Chautauqua and declared: “I hate war.” His warning still speaks to our age.

I arrived in Beijing on the day martial law was declared in 1989. What I witnessed has stayed with me ever since. My full conversation with @ezraklein is out now.

I first met Xi Jinping in 1986, when he was vice mayor of Xiamen. Great to speak with @ezraklein about China, its leadership, and the years that shaped its direction. My full interview with the @nytimes is out now.

We live in the decade of living dangerously. Read on: open.substack.com/pub/mrkrud…

Great to run into Alastair Campbell in Hong Kong and discuss things theological and technological.

The US-China relationship has entered a new phase of leader-driven détente. We must now try to understand where it’s headed next. This week Asia Society brought together some of the sharpest minds in policy, business and academia for our inaugural Washington China Dialogues to examine China from the Inside Out.

During my time as Ambassador, I delivered a series of lectures on deterrence. I’ve shared the first one on my Substack as I believe they are just as relevant today. open.substack.com/pub/mrkrud…

Great to be at @AsiaSociety in Tokyo. And to spend time with senior Japanese government officials on US-China-Japan and the ongoing challenges arising from Taiwan. @AsiaSocietyJP

29 years since the Bringing Them Home report. 18 years since the Apology. As the Healing Foundation reminds us today, saying sorry was just the first step. There’s much to be done on the long road towards reconciliation. Proud of our team at the National Apology Foundation and all of the efforts that continue around Australia to close the gap.

I’ve started a Substack as a place to share my thoughts on the world and where it may be headed next. mrkrudd.substack.com

Many of the biggest questions about what the future looks like for our kids, and our grandkids remain unanswered. I hope to make a modest contribution to the conversation: mrkrudd.substack.com/

Today I’m launching a Substack. I’ll use this space to share some reflections on the world and the future now unfolding before us. Read on: mrkrudd.substack.com/

Never die wondering. Work out what you believe in, and do it. My commencement address to the University of Southern California's Sol Price School of Public Policy graduating class of 2026.

China’s President Xi appears to have has laid out a new strategic framework for the bilateral relationship. He calls it “constructive strategic stability”. Which sounds like a form of leader-led detente but still with deep red lines on Taiwan. On US @ABCNewsLive just now discussing this and other new directions discussed so far during the US-China summit in Beijing.

Today is a big day for the world's two largest economies as Trump and Xi meet in Beijing. My comments on Fox News with @SandraSmithFox this morning.

President Trump and President Xi have very different negotiating styles. But both Washington and Beijing now want stability.

What happens in Beijing this week will shape the future of US-China business. And US-China business will shape the future of the global economy. My view: both Washington and Beijing now have a shared interest in stabilising the relationship for the period ahead. Great to join the U.S. Chamber and AmCham China for the China Business Conference

Good to be back on stage at Asia Society in New York with @ianbremmer from Eurasia Group. Great discussion on the Trump-Xi Summit; China's posture towards resolving Iran/Strait of Hormuz; as well as what's happening in what has become the forgotten war in Ukraine. And beyond geopolitics, what all this means for the global economy @AsiaSociety @AsiaPolicy

This week’s US-China meeting will have far-reaching consequences for the global economy, security and technology. My conversation with Bret Baier on Fox News.

There are challenges that all countries face that cross borders. The US and China have an opportunity to collaborate on these shared challenges that also affect us all. Like accelerated clinical trials for drugs to treat a wide spectrum of cancers.